Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03372564 · ClinicalTrials.gov registry record · NA

CREST: Capsular Repair During Hip Arthroscopy

A NA study of Hip Arthroscopy, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
250
Enrollment target
3
Study locations

NCT03372564: Active NA study of Hip Arthroscopy, sponsored by Mayo Clinic.

NCT03372564 is a NA study of Hip Arthroscopy that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 1,102-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03372564, a NA study of Hip Arthroscopy, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
3
Study locations

Study Summary

Capsular REpair randomiSed controlled Trial (CREST) is a multi-center, randomized controlled trial with a sample size of 240 patients (120 patients in each group). The primary outcome measure is functional outcome as measured by the change in Hip Outcome Score at 6 months with secondary outcomes being hip range of motion, i-HOT 12, overall satisfaction, and VAS. Patients are stratified based on gender. Patients, outcome assessors, and data analysts are blinded to surgical allocation. Using an intention-to-treat approach, outcome analyses will be performed using an analysis of covariance and descriptive statistics.

Primary Outcome

The main outcome assessed will be hip function including change in percentage of Hip outcome score (HOS score) from baseline to 6 month follow-up. The subscale of ADL (activities of daily living) and Sport will be utilized. each HOS subscale is calculated from 0 to 100%, with 100% being the best score.

Conditions Studied

Interventions

  • PROCEDURE Hip Capsule Repair

Study Locations (3)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Illinois

  • American Hip Institute - Westmont

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2017-11-07
Est. Completion 2040-12
Phase NA
Mayo Clinic

2,844 total trials

What the registry record for NCT03372564 still lists

NCT03372564 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,102-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Hip Arthroscopy appearing as the primary indexed condition, and to 1 intervention - of which Hip Capsule Repair is the first listed.

NCT03372564 reports a single indexed study location in Arizona, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03372564 about?

NCT03372564 is a clinical study titled "CREST: Capsular Repair During Hip Arthroscopy". Capsular REpair randomiSed controlled Trial (CREST) is a multi-center, randomized controlled trial with a sample size of 240 patients (120 patients in each group). The primary outcome measure is functional outcome as measured by the change in Hip Outcome Score at 6 months with secondary outcomes bei...

What is the current status of trial NCT03372564?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2017-11-07. Estimated completion is 2040-12.

What conditions does trial NCT03372564 study?

This clinical trial studies the following conditions: Hip Arthroscopy.

What interventions are being tested in trial NCT03372564?

The interventions under investigation include: Hip Capsule Repair (PROCEDURE).

Who is sponsoring clinical trial NCT03372564?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03372564 being conducted?

This trial has 3 study locations across Arizona, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Arthroscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03372564's enrollment target sits among peer trials

250 2nd of 10 the highest of 10 other Hip Arthroscopy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hip Arthroscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03372564, the US trial registry maintained by the National Library of Medicine. NCT03372564 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.